TS-ONE
  • About TS-ONE ®
  • Patient Information
  • Useful Information
  • Contact

  • 1. What’s TS-ONE ®

  • 2. Approved Countries

  • 3. Scientific Information

  • 4. Administration

Phase III Studies and Guideline Recommendations*


Gastric Cancer

Colorectal Cancer

Pancreatic Cancer

Biliary Tract Cancer

Lung Cancer

Breast Cancer

Head and Neck Cancer


* In Hong Kong, TS-ONE ® is indicated for post operative adjuvant chemotherapy for locally advanced (stage II (excluding T1), IIIA or IIIB) gastric cancer 2.

Head and Neck Cancer
  • Tsukahara K. et al., 2015. Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC).
    PLoS One, 10(2), 0116965

This Site is intended for Hong Kong healthcare professionals only. Products discussed herein may have different labeling in different countries. TS-ONE® is a registered trademark of TAIHO PHARMACEUTICAL CO., LTD. and used under license. Copyright © TAIHO PHARMACEUTICAL CO., LTD. 2020 All rights reserved.